# Clinical Study of EBV-LMP1 Targeted DNAzyme to Treat Nasopharyngeal Carcinoma

> **NCT01449942** · PHASE1,PHASE2 · COMPLETED · sponsor: **Xiangya Hospital of Central South University** · enrollment: 40 (actual)

## Conditions studied

- Nasopharyngeal Carcinoma

## Interventions

- **BIOLOGICAL:** DNAzyme targeting EBV-LMP1 (DZ1)
- **OTHER:** Saline

## Key facts

- **NCT ID:** NCT01449942
- **Lead sponsor:** Xiangya Hospital of Central South University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-05
- **Primary completion:** 2011-04
- **Final completion:** 2011-09
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2011-10-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01449942

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01449942, "Clinical Study of EBV-LMP1 Targeted DNAzyme to Treat Nasopharyngeal Carcinoma". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01449942. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*